Open-Label Treatment with Desvenlafaxine in Postmenopausal Women with Major Depressive Disorder Not Responding to Acute Treatment with Desvenlafaxine or Escitalopram

By Soares Claudio N.  

CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. : 227-238

Adis International

Access to resources Recommend Favorite

Desvenlafaxine delightful in depressive disorder

By  

Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Agomelatine for the treatment of major depressive disorder

By Carney Regina M   Shelton Richard C  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2411-2419

Informa Healthcare

Access to resources Recommend Favorite

Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin–norepinephrine reuptake inhibitor

By Nichols Alice I   Tourian Karen A   Tse Susanna Y   Paul Jeffrey  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1565-1574

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients

By Yang Lily P.H.   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite